Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
WuXi Biologics Holdings has raised HK$6.1bn ($787.5m) after selling a block of shares in WuXi Biologics (Cayman), the fourth time it has trimmed its position in the company this year. -
City workers used to go to ubiquitous sandwich chain Pret A Manger because it was close to the office. Now, the UK government wants us to go to our offices because they’re near a Pret. Yes, the City’s retail and commercial property economies are in trouble, but cajoling people back to the office is not the answer.
-
The European Securities and Markets Authority (ESMA) has said that making sure staff could work remotely hindered the ability of financial firms to work on regulatory and IT projects, in a final report calling for the implementation of a set of rules on settlement discipline — including on mandatory buy-ins — to be delayed until 2022.
-
Beijing-headquartered Asian Infrastructure Investment Bank (AIIB) has played a pre-eminent role in tackling Covid-19 this year, mainly by offering financial support to countries like Uzbekistan, Pakistan and Vietnam to combat the impact of the pandemic. But its work is not nearly over, as second and third waves of the coronavirus hit countries around the world.
-
Colombian airline Avianca is confident it will be able to exit bankruptcy soon after the Colombian government said it would provide just over 30% of the new money required in the company’s proposed debtor-in-possession (DIP) financing — much to the shock of some politicians in the country.
-
Ecuador has passed the final hurdle on its way to completing the restructuring of its $17.4bn of international bonds after reaching an agreement on a new IMF programme.
